The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zyloric 100 mg Tablets

Aspen Pharma Trading LimitedPA1691/002/001

Main Information

Trade NameZyloric 100 mg Tablets
Active SubstancesAllopurinol
Dosage FormTablet
Licence HolderAspen Pharma Trading Limited
Licence NumberPA1691/002/001

Group Information

ATC CodeM04AA Preparations inhibiting uric acid production
M04AA01 allopurinol


License statusAuthorised
Licence Issued01/04/1978
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back